Fibromed: Clearing the haze

Emerging Company Profile

Fibromed Inc. sees a clear route to the market in the temporary haze created by photorefractive keratotomy (PRK), an increasingly popular technique for laser eye surgery. Although Fibromed's core technology, lysyl oxidase inhibition, has a multitude of potential applications, the company is focusing its resources on getting an ophthalmic ointment designed to speed recovery from PRK into the clinic...